Who owns Alia Therapeutics?

Alia Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Telethon, since 2021.

When did Sofinnova Partners acquire Alia Therapeutics?

Sofinnova Partners acquired Alia Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Alia Therapeutics

Alia Therapeutics

Biotech·

Italy·Active·5yr hold

Alia Therapeutics is a healthcare / biotech company, headquartered in Italy.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQItaly

SectorHealthcare / Biotech

Italian company developing next-generation CRISPR-based gene editing therapies for retinal degeneration, a University of Trento spin-off.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings